Feedback / Questions
MRO-002 - Myrobalan Therap
https://www.businesswire.com/news/home/20250312951560/en/Myrobalan-Therapeutics-Awarded-a-Grant-from-the-National-Multiple-Sclerosis-Society-to-Advance-Development-of-MRO-002-in-Multiple-Sclerosis
Mar 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next